Sanofi’s (NYSE:SNY) subsidiary Genzyme recently announced that it has received approval for the production of Fabrazyme (agalsidase beta) at its Framingham manufacturing facility from the European Medicines Agency (“EMA”).
The approval of the Framingham plant comes as a relief for Genzyme, which has been facing supply problems ever since manufacturing issues cropped up at its Allston Landing plant in the US in June 2009.
The Allston manufacturing facility used to produce Genzyme’s key … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here